E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/15/2017 in the Prospect News Bank Loan Daily and Prospect News Investment Grade Daily.

S&P: Magellan notes rated BBB-

S&P said it affirmed the BBB- long-term corporate credit rating on Magellan Health Inc. and assigned a BBB- issue-level rating on the company's senior unsecured notes.

The outlook is stable.

The agency said Magellan is issuing $300 million in seven-year senior unsecured notes and entering into a credit agreement that provides for a $400 million five-year revolver (up from $250 million) and a $350 million five-year term loan.

It will use the proceeds to repay its existing secured term loan debt of $606 million and transaction costs.

“We believe MGLN may use remaining debt proceeds, cash on hand, and revolving borrowings to finance its pending $400 million acquisition of Senior Whole Health, expected to close by the first-quarter 2018,” S&P said in a news release.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.